![Discovery Labs Logo](/news-release/logo/234081/0/234081.jpg?lastModified=12%2F09%2F2016%2023%3A06%3A46&size=2)
Discovery Labs and FDA to Meet On June 2, 2009 to Discuss SURFAXIN Complete Response Letter
11 mai 2009 16h30 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., May 11, 2009 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) has received written notification from the U.S. Food and Drug Administration (FDA) that an end-of-review...
![Discovery Labs Logo](/news-release/logo/234081/0/234081.jpg?lastModified=12%2F09%2F2016%2023%3A06%3A46&size=2)
Discovery Labs to Raise $11.3 Million in Registered Direct Offering
08 mai 2009 15h06 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., May 8, 2009 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) today announced that it has entered into definitive agreements with select institutional investors to raise...
![Discovery Labs Logo](/news-release/logo/234081/0/234081.jpg?lastModified=12%2F09%2F2016%2023%3A06%3A46&size=2)
Discovery Labs' Surfaxin(r) Significantly Improves Lung Surfactant Distribution in Preclinical RDS Model
05 mai 2009 07h00 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., May 5, 2009 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO), announced that data from a preclinical study using Surfaxin(r) (lucinactant) in a well-established preterm...
![Discovery Labs Logo](/news-release/logo/234081/0/234081.jpg?lastModified=12%2F09%2F2016%2023%3A06%3A46&size=2)
Discovery Labs' KL4 Surfactant Shows Physiologic and Survival Benefit in a Preclinical Model for Severe Respiratory Condition -- Acute Lung Injury
04 mai 2009 07h00 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., May 4, 2009 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) announced that data from a preclinical study using KL4 surfactant demonstrated a favorable physiologic...
![Discovery Labs Logo](/news-release/logo/234081/0/234081.jpg?lastModified=12%2F09%2F2016%2023%3A06%3A46&size=2)
Discovery Labs Receives Notice of Allowance for Patent to Treat Infants At Risk of Developing Bronchopulmonary Dysplasia
01 mai 2009 07h30 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., May 1, 2009 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) today announces that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO)...
![Discovery Labs Logo](/news-release/logo/234081/0/234081.jpg?lastModified=12%2F09%2F2016%2023%3A06%3A46&size=2)
Discovery Labs Reports First Quarter 2009 Financial Results
28 avr. 2009 17h55 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., April 28, 2009 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) today announced financial results for the first quarter ended March 31, 2009.
For the quarter ended...
![Discovery Labs Logo](/news-release/logo/234081/0/234081.jpg?lastModified=12%2F09%2F2016%2023%3A06%3A46&size=2)
Discovery Labs Presents Pharmacoeconomic Data Linking Decreased Hospital Costs to Reduction in Reintubation Following Surfaxin Use
27 avr. 2009 07h00 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., April 27, 2009 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) today announced that it presented a pharmacoeconomic analysis of data from its SELECT and STAR Phase 3...
![Discovery Labs Logo](/news-release/logo/234081/0/234081.jpg?lastModified=12%2F09%2F2016%2023%3A06%3A46&size=2)
Discovery Labs Receives Complete Response From FDA for Surfaxin(r) for Prevention of RDS
20 avr. 2009 07h30 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., April 20, 2009 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) today announced that, on April 17, 2009, it received a Complete Response letter from the U.S. Food and...
![Discovery Labs Logo](/news-release/logo/234081/0/234081.jpg?lastModified=12%2F09%2F2016%2023%3A06%3A46&size=2)
Discovery Labs Provides Update Regarding Surfactant Aerosol Generation Technology
14 avr. 2009 07h00 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., April 14, 2009 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) today announces that it continues to make significant progress in the development of its proprietary...
![Discovery Labs Logo](/news-release/logo/234081/0/234081.jpg?lastModified=12%2F09%2F2016%2023%3A06%3A46&size=2)
Discovery Labs to Highlight Respiratory Pipeline at the Future Leaders in the Biotech Industry Conference
30 mars 2009 09h00 HE
|
Discovery Laboratories, Inc.
WARRINGTON, Pa., March 30, 2009 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) will present to the investment community at the BioCentury Future Leaders in the Biotech Industry...